Tolvaptan, an FDA-approved drug, inhibits Zika virus infection both in vitro and in vivo.
| Autor: | Xiuxiu Chen, Ronghua Luo, Zhaiwen Yao, Changbo Zheng, Qiuju Tang, Wei Pang, Fang Wang, Liumeng Yang, Sidong Xiong, Yongtang Zheng |
|---|---|
| Předmět: | |
| Zdroj: | Journal of Chinese Pharmaceutical Sciences; Mar2021, Vol. 30 Issue 3, p218-229, 12p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|